Tesla China Sales Surge 40% in May, But Core Thesis Unchanged

What happened

Tesla's Shanghai Gigafactory delivered 85,982 EVs in May, a nearly 40% jump year-over-year, as China's overall EV market rebounded 12%. While the volume beat supports the auto cash-generation narrative, it does not materially alter the investment thesis centered on robotaxi scaling and AI capex discipline. China remains a highly competitive market where pricing pressure persists, and regulatory credit revenue continues to erode. The company's 2026 capex plan above $25B and a P/E of 354x mean near-term delivery wins are insufficient to justify valuation without concurrent autonomy monetization progress. This data point is positive but does not move the needle on the key swing factors: robotaxi expansion beyond Texas and sustainable free cash flow.

Implication

Near-term, the May delivery surge provides a modest tailwind to Q2 volume expectations, but it does not address the core risk: the sustainability of >$25B capex without proven autonomy revenue. China's EV market is fiercely competitive, and Tesla's margin improvement in Q1 may be challenged if price cuts resume. The robotaxi monetization path remains the primary catalyst, with regulatory patchwork still a key headwind. Until Tesla demonstrates paid FSD subscription growth and robotaxi expansion beyond two Texas metros, valuation multiples should compress. The attractive entry remains around $320, with $480 as a trim zone; this news does not change those thresholds.

Thesis delta

The China sales data supports the base-case assumption that core auto remains cash-generative, but it does not reduce the burden of proof on robotaxi commercialization. The thesis delta is neutral: the probability of the base case ($400) may edge slightly higher, but the bear case regulatory risks and capex intensity remain unchanged. No adjustment to rating or price targets is warranted.